Early screening and care for sickle cell in newborns could save lives
NCT ID NCT07488520
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test 120 babies in Côte d'Ivoire for sickle cell disease using a simple point-of-care test. Babies who test positive will start comprehensive care early, including medicines and vaccines. Researchers want to see if this approach reduces serious health problems and deaths compared to usual care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE (SCD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yopougon SCD Center of Excellence
Yopougon, Côte d’Ivoire
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can gene therapy free sickle cell patients from painful crises?
- Simple breathing device may speed recovery from a deadly sickle cell complication
- Could ketamine beat opioids for sickle cell pain in kids?
- New study aims to track dangerous infections in kids with sickle cell disease
- Major study to decide: transplant or medication for kids with sickle cell?
- Could a simple seed ease sickle cell pain? new study hopes to find out